NSN 5340-01-012-6782 of Slide Drawer Extens - Product Details
Just NSN Parts, owned and operated by ASAP Semiconductor, is an industry-leading distributor of NSN 5340-01-012-6782 parts applicable in the aviation and defense industries. We aim to simplify the NSN 5340-01-012-6782 parts procurement process by enabling our customers to search through our inventory quickly and efficiently. Type in your desired NSN 5340-01-012-6782 part number such as 512308-1, 310012 into our search engine and, in a matter of seconds, available stock will appear.
We pride ourselves on our attention to detail and focus on quality control. We are FAA AC 0056B accredited and AS9120B, ISO 9001:2015 certified. We offer our customers a personalized and reliable service that will change your parts procurement process. If you would like to receive a quote today, fill out a request for quote form today.
Alternative NSN: 5340-01-012-6782 |
Item Name:Slide Drawer Extens |
FSG: 53 Hardware and Abrasives |
Federal Supply Class (FSC): 5340 Hardware Commercial |
NIIN: 010126782 |
NCB Code: USA (01) |
Manufacturers: Itt Federal Laboratories Div Of , Jonathan Engineered Solutions Corp |
Manufacturer's List for NSN 5340-01-012-6782, 5340010126782
Part Number Related To NSN 5340-01-012-6782, 5340010126782
Part No | NSN | Item Name | QTY | RFQ |
---|---|---|---|---|
512308-1 | 5340-01-012-6782 | slide drawer extens | Avl | RFQ |
310012 | 5340-01-012-6782 | slide drawer extens | Avl | RFQ |
Characteristics Data of NSN 5340010126782
MRC | Criteria | Characteristic |
---|---|---|
ABGL | WIDTH | 0.595 INCHES MINIMUM AND 0.645 INCHES MAXIMUM |
ATEM | EXTENDED LENGTH | 38.970 INCHES MINIMUM AND 39.030 INCHES MAXIMUM |
AXGY | MOUNTING METHOD | UNTHREADED HOLE |
BWJF | SIDE FOR WHICH DESIGNED | LEFT HAND |
CBRJ | CLOSED LENGTH | 17.970 INCHES MINIMUM AND 18.030 INCHES MAXIMUM |
MATT | MATERIAL | STEEL OVERALL |
SFTT | SURFACE TREATMENT | CADMIUM OVERALL AND CHROMATE OVERALL |
STDC | SURFACE TREATMENT DOCUMENT AND CLASSIFICATION | QQ-P-416,TYPE 2,CLASS 2 FED SPEC ALL TREATMENT RESPONSES OVERALL |